Nicolas Simon (N Simon)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

European journal of hospital pharmacy : science and practice

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Centre Hospitalier Régional Universitaire de Lille

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Hospitalier Régional Universitaire de Lille Sep 01 2019

France

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille Sep 01 2013 - Aug 31 2019

France

Maître de Conférences des Universités - Praticien Hospitalier

Hôpitaux Universitaires de Genève Nov 01 2017 - Oct 31 2018

Switzerland

Mobilité scientifique :: Pharmacie des HUG

Centre Oscar Lambret Jan 01 2010 - Aug 31 2013

France

Assistant Hospitalo-Universitaire

Université de Lille II Dec 01 2008 - Dec 31 2009

France

Attaché Temporaire d'Enseignement et de Recherche

Publications

Marine Roche, Damien Rousseleau, Cécile Danel, Héloïse Henry, Gilles Lebuffe, Pascal Odou, Damien Lannoy, Nicolas Simon
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study. European journal of hospital pharmacy : science and practice (2024)
Fanny Moreau, Bertrand Décaudin, Michel Tod, Pascal Odou, Nicolas Simon
Impact of the use of a drug-drug interaction checker on pharmacist interventions involving well-known strong interactors. European journal of hospital pharmacy : science and practice (2024)
Myriam Bouchfaa, Michèle Vasseur, Justin Courtin, Marine Pinturaud, Nicolas Beauval, Delphine Allorge, Pascal Odou, Nicolas Simon
Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Guillaume Saint-Lorant, Michèle Vasseur, Delphine Allorge, Nicolas Beauval, Nicolas Simon, Pascal Odou
Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occupational and environmental medicine 80 (3) (2023)
Elodie Cuvelier, Houda Khazri, Cloé Lecluse, Benjamin Hennart, Ali Amad, Jean Roche, Michel Tod, Guillaume Vaiva, Olivier Cottencin, Pascal Odou, Delphine Allorge, Bertrand Décaudin, Nicolas Simon
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational Study. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Guillaume Saint-Lorant, Michèle Vasseur, Delphine Allorge, Nicolas Beauval, Nicolas Simon, Pascal Odou
Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occupational and environmental medicine 80 (3) (2023)
Guillaume Saint-Lorant, Michèle Vasseur, Delphine Allorge, Nicolas Beauval, Nicolas Simon, Pascal Odou
Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occupational and environmental medicine 80 (3) (2023)
Guillaume Saint-Lorant, Michèle Vasseur, Delphine Allorge, Nicolas Beauval, Nicolas Simon, Pascal Odou
Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occupational and environmental medicine (2023)
Elodie Cuvelier, Houda Khazri, Cloé Lecluse, Benjamin Hennart, Ali Amad, Jean Roche, Michel Tod, Guillaume Vaiva, Olivier Cottencin, Pascal Odou, Delphine Allorge, Bertrand Décaudin, Nicolas Simon
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational Study. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Elodie Cuvelier, Houda Khazri, Cloé Lecluse, Benjamin Hennart, Ali Amad, Jean Roche, Michel Tod, Guillaume Vaiva, Olivier Cottencin, Pascal Odou, Delphine Allorge, Bertrand Décaudin, Nicolas Simon
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational Study. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Marine Roche, Cécile Danel, Nicolas Simon, Mostafa Kouach, Myriam Bouchfaa, Christophe Berneron, Pascal Odou, Damien Lannoy
Cistracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages: A Stability Study Involving Four Degradation Products. Pharmaceutics 15 (5) (2023)
Mathilde Sourisseau, Emmanuel Faure, Hélène Béhal, Paul Chauvet, Micha Srour, Antoine Capes, Valérie Coiteux, Léonardo Magro, Serge Alfandari, Enagnon Kazali Alidjinou, Nicolas Simon, Fanny Vuotto, Micheline Karam, Karine Faure, Ibrahim Yakoub Agha, David Beauvais
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients. Blood advances (2022)
Quentin Hiver, Héloïse Henry, Michèle Vasseur, Elodie Cuvelier, Emilie Le Rhun, Anthony Turpin, Bertrand Décaudin, Pascal Odou, Nicolas Simon
Ethanol Exposure During the Intravenous Administration of Chemotherapeutic Drugs: An Analysis of Clinical Practice and a Literature Review. JCO oncology practice 18 (5) (2022)
Fanny Moreau, Nicolas Simon, Julia Walther, Mathilde Dambrine, Gaetan Kosmalski, Stéphanie Genay, Maxime Perez, Dominique Lecoutre, Stéphanie Belaiche, Chloé Rousselière, Michel Tod, Bertrand Décaudin, Pascal Odou
Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively? Metabolites 11 (3) (2021)
Ophélie Petit, Guillaume Saint-Lorant, Michèle Vasseur, Julie Boucher, Justin Courtin, Marine Pinturaud, Delphine Allorge, Bertrand Decaudin, Nicolas Simon, Pascal Odou
Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (8) (2020)
Nicolas Simon, Nicolas Guichard, Pascal Odou, Bertrand Décaudin, Pascal Bonnabry, Sandrine Fleury-Souverain
Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces. PloS one 15 (6) (2020)
Nicolas Simon, Pascal Odou, Bertrand Décaudin, Pascal Bonnabry, Sandrine Fleury Souverain
Occupational exposure to conventional antineoplastic drugs: can it be further limited? European journal of hospital pharmacy : science and practice 27 (5) (2019)
Florence Bourdon, Nicolas Simon, Damien Lannoy, Christophe Berneron, Bertrand Décaudin, Laurence Reumaux, Alain Duhamel, Pierre Richart, Pascal Odou
Quality control and stability of ketamine, remifentanil, and sufentanil syringes in a pediatric operating theater. Paediatric anaesthesia 29 (2) (2019)
Nicolas Simon, Pascal Odou, Bertrand Decaudin, Pascal Bonnabry, Sandrine Fleury-Souverain
Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (4) (2019)
Nicolas Simon, Delphine Barnoud, Bénédicte Bruno, Michèle Vasseur, Johana Béné, Pascal Odou
Should we replace etoposide phosphate by etoposide for allogeneic hematopoetic stem-cell transplantation in children? Pediatric blood & cancer 65 (7) (2018)
Michèle Vasseur, Nicolas Simon, Chloé Picher, Camille Richeval, Marion Soichot, Luc Humbert, Christine Barthélémy, Sandrine Fleury-Souverain, Pascal Bonnabry, Bertrand Décaudin, Delphine Allorge, Pascal Odou
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. PloS one 13 (8) (2018)
Delphine Barnoud, Claire Pinçon, Bénédicte Bruno, Johana Béné, Sophie Gautier, Annie Lahoche, Nadine Petitpain, Michèle Vasseur, Christine Barthélémy, Bertrand Décaudin, Nicolas Simon, Pascal Odou
Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation. Pediatric blood & cancer 65 (7) (2018)
F Morschhauser, B Dekyndt, C Baillet, C Barthélémy, E Malek, J Fulcrand, P Bigot, D Huglo, B Décaudin, Nicolas Simon, P Odou
A new pharmacokinetic model for 90Y-ibritumomab tiuxetan based on 3-dimensional dosimetry. Scientific reports 8 (1) (2018)

Nicolas Simon.css-eqlu8i{font-size:small;padding-left:4px;} (N Simon)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Simon (N Simon)